LAB Standard BioTools Inc.

LAB Standard BioTools Inc.

Healthcare · Medical Devices

Market read

POC $0.88 · VWAP $1.01 · -37.5% vs 12m avg buyer

collapse vol: normalgaps: stablechurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

1 watchlist

LAB Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist LAB belongs to, members best 30-day change first — LAB highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

Next earnings LAB reports in 17 days Nov 3

Last report Aug 5

Reported the quarter ending 2026-06-30: revenue $20M, diluted EPS -$0.07, net income -$27M (SEC filing). Across the print the stock moved -2.5% (close before → first close after).

full note →

Against street estimates

How LAB's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 10 quarters · newest report Aug 5 · projection Oct 16

Result
Aug 5 -0.03-0.06-100.0%Miss
May 5 -0.02-0.02 GAAP ≠ +15.5%Beat
Feb 24 -0.020.07+368.8%Beat
Nov 4 '25 -0.02-0.04-101.5%Miss
Aug 11 '25 -0.04-0.04+0.3%In line
May 6 '25 -0.04-0.05-19.5%Miss
Feb 26 '25 -0.03-0.05-64.7%Miss
Oct 30 '24 -0.07-0.03+53.9%Beat